News
August marks Appendiceal Cancer Awareness Month. It's a rare form of gastrointestinal cancer with only 3,000 patients in the ...
1h
FOX 13 Tampa Bay on MSNRare cancer on the rise in younger patients; survivor shares warningAugust marks Appendiceal Cancer Awareness Month. It's a rare form of gastrointestinal cancer with only 3,000 patients in the U.S. diagnosed annually.
DelveInsight's, “Microbiome Disease Pipeline Insights 2025” report provides comprehensive insights about 140+ companies and 180+ pipeline drugs in Microbiome Disease pipeline landscape. It covers the ...
People who avoid meat are less likely to develop a range of cancers, according to one of the most detailed studies of ...
Family warns of deadly waterborne bacteria after beloved coastal resident dies from Vibrio infection
Basil Kennedy’s loved ones urge those with health conditions to avoid warm coastal waters and raw shellfish, as Vibrio vulnificus infections surge amid rising temps ...
Scientists have identified a range of gut bacteria and metabolites that could dramatically improve the detection and treatment of gastrointestinal diseases (GIDs), including gastric cancer (GC), ...
Genetic testing of gastrointestinal cancer patients prior to starting chemotherapy proved feasible in a prospective study and ...
Treatment decisions for older adults after CDK4/6 inhibitors should be tailored, explained Courtney Moore, APRN, FNP-C, OCN.
Study participants were randomly assigned to receive either oral vepdegestrant (n=313) or intramuscular fulvestrant (n=311). The primary endpoint was progression free survival (PFS) among all patients ...
In an early trial, a one-size-fits-all vaccine showed promise in preventing hard-to-treat pancreatic cancers from coming back ...
Some oncologists and researchers have raised concerns about delays in the completion of confirmatory trials, but FDA now has new tools to push them ahead.
Revenue (GAAP) for Q2 2025 was $25.7 million, missing expectations by 48.3% compared to the $49.71 million estimate. Net loss (GAAP) improved year-over-year to $56.4 million for Q2 YTD 2025, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results